First AD

Second AD

                Treatment Strategies in 2L R/R FL: When to Treat vs Observe in Relapsed Disease

Video content above is prompted by the following:

For patients who have disease relapse or POD progression of disease after 1

 line therapy, some may benefit from a second period of observation. 

When do you treat versus vs observe in the 2L setting?

Video Series

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Clinical Insights on R/R Follicular Lymphoma: ASH 2024 Highlights

Peer Exchange

Panelists discuss how the treatment approach for relapsed or progressive follicular lymphoma (R/R FL) in the second-line (2L) setting is evolving, focusing on the role of observation vs intervention and the potential impact of ASH 2024 updates, including the inMIND study with tafasitamab and the EPCORE NHL-2 trial with epcoritamab + R2.